LianBio Uncategorized Contracts & Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
LianBio
Biotechnology
NY
2023
Second Amendment
LianBio
Biotechnology
2022
Description of
LianBio
Biotechnology
NY
2022
Option Agreement, dated October 18, 2021, by and among LianBio, LianBio Ophthalmology and Tarsus Pharmaceuticals, Inc
LianBio
Biotechnology
2021
Specimen Certificate evidencing the Ordinary Shares
LianBio
Biotechnology
2021
Director Nomination Agreement, dated October 8, 2021, by and among LianBio and Perceptive Life Sciences Master Fund, Ltd., LEV LB Holdings, LP, Perceptive Xontogency Venture Fund,...
LianBio
Biotechnology
2021
Novation Agreement, dated October 11, 2020, by and among LianBio, LianBio Licensing LLC and QED Therapeutics, Inc
LianBio
Biotechnology
NY
2021
Exclusivity Agreement, dated October 16, 2019, by and between LianBio and BridgeBio Pharma LLC
LianBio
Biotechnology
NY
2021
Equity Holders Agreement, dated August 10, 2020, by and among LianBio, Lian Cardiovascular and MyoKardia, Inc
LianBio
Biotechnology
2021
Amended and Restated Option Agreement, dated as of August 10, 2020, by and among LianBio and MyoKardia, Inc. and QED Therapeutics, Inc
LianBio
Biotechnology
2021
Information Rights Letter of BridgeBio Pharma LLC, dated October 16, 2019, by and between the Company and BridgeBio Pharma LLC
LianBio
Biotechnology
2021